Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.92T | 3.87T | 3.54T | 2.80T | 2.19T | 2.44T | Gross Profit |
824.80B | 1.21T | 1.04T | 779.58B | 581.05B | 695.82B | EBIT |
348.83B | 607.19B | 490.69B | 317.01B | 167.33B | 250.71B | EBITDA |
500.52B | 787.00B | 658.49B | 473.14B | 309.67B | 379.30B | Net Income Common Stockholders |
264.49B | 393.43B | 326.40B | 224.93B | 106.24B | 153.84B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
150.59B | 403.18B | 289.98B | 316.67B | 243.13B | 249.67B | Total Assets |
3.51T | 5.64T | 4.88T | 4.35T | 3.78T | 3.65T | Total Debt |
966.25B | 1.27T | 1.12T | 1.01T | 965.85B | 1.07T | Net Debt |
818.04B | 867.24B | 826.58B | 692.46B | 724.04B | 818.32B | Total Liabilities |
1.71T | 2.44T | 2.20T | 1.99T | 1.77T | 1.80T | Stockholders Equity |
1.72T | 3.03T | 2.54T | 2.23T | 1.91T | 1.77T |
Cash Flow | Free Cash Flow | ||||
72.67B | 231.83B | 22.94B | 138.01B | 172.58B | 110.47B | Operating Cash Flow |
234.03B | 434.78B | 206.47B | 300.97B | 354.13B | 295.18B | Investing Cash Flow |
-147.35B | -204.42B | -169.52B | -143.57B | -163.06B | -190.93B | Financing Cash Flow |
22.85B | -122.04B | -66.61B | -93.87B | -199.67B | -3.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $2.68B | 8.15 | 19.13% | 1.68% | -0.47% | -34.74% | |
78 Outperform | $27.61B | 10.66 | 13.15% | 2.91% | -1.87% | -6.15% | |
74 Outperform | $129.06B | 21.08 | 27.91% | 1.28% | -20.93% | -34.33% | |
68 Neutral | $6.17B | 9.23 | 17.34% | 1.98% | 11.36% | 13.78% | |
66 Neutral | $162.39B | 15.41 | 55.36% | 1.64% | -3.36% | 9.59% | |
62 Neutral | $8.17B | 12.83 | 0.26% | 3.07% | 3.83% | -16.44% | |
55 Neutral | $7.30B | 46.40 | -10.11% | 1.19% | -19.08% | -136.41% |